Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web‐based survey by the European Network of Uropathology

Pathological evaluation of lymphadenectomy specimens plays a pivotal role in accurate lymph node (LN) staging. Guidelines standardising the gross handling and reporting of pelvic LN dissection (PLND) in prostate (PCa) and bladder (BCa) cancer are currently lacking. This study aimed to establish current practice patterns of PLND evaluation among pathologists.

[1]  A. Haese*,et al.  Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer. , 2018, European urology.

[2]  N. Lawrentschuk,et al.  Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer , 2018, Nature Reviews Urology.

[3]  Lili Zhao,et al.  High Variability in Lymph Node Counts Among an International Cohort of Pathologists: Questioning the Scientific Validity of Node Counts. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  E. Compérat,et al.  Microbiota: Bacteriophage diversity in the urinary microbiome , 2018, Nature Reviews Urology.

[5]  H. G. van der Poel,et al.  The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. , 2017, European urology.

[6]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[7]  Mark W. Ball,et al.  Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series , 2017, BJU international.

[8]  S. Rais-Bahrami,et al.  Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy , 2017, International journal of surgical pathology.

[9]  T. H. van der Kwast,et al.  Lymph node staging in prostate cancer: perspective for the pathologist , 2016, Journal of Clinical Pathology.

[10]  Anirban P. Mitra,et al.  Radical cystectomy with super‐extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes , 2016, BJU international.

[11]  H. S. Kim,et al.  Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis , 2015, BMC Cancer.

[12]  M. Varma,et al.  Effective maybe, but is it cost‐effective? , 2015, Histopathology.

[13]  J. Witjes,et al.  The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. , 2014, European urology.

[14]  F. Montorsi,et al.  Total submission of lymphadenectomy tissues removed during radical prostatectomy for prostate cancer: possible clinical significance of large-format histology. , 2014, Human pathology.

[15]  J. Witjes,et al.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.

[16]  B. Delahunt,et al.  Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases , 2014, Histopathology.

[17]  Y. Lotan,et al.  Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. , 2013, European urology.

[18]  B. Trock,et al.  Comparison of Biochemical Recurrence–Free Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer , 2013, International journal of surgical pathology.

[19]  K. Sotlar,et al.  Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost‐benefit analysis , 2012, BJU international.

[20]  F. Montorsi,et al.  Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer , 2012, International journal of urology : official journal of the Japanese Urological Association.

[21]  M. Menon,et al.  Characteristics of Pelvic Lymph Node Metastases in Prostatic Adenocarcinoma , 2012, International journal of surgical pathology.

[22]  S. Mendrinos,et al.  Periprostatic lymph node metastasis in prostate cancer and its clinical significance , 2012, Histopathology.

[23]  J. Hecht.  To count and how to count, that is the question. , 2011, American journal of clinical pathology.

[24]  C. Stief,et al.  Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy , 2011, Annals of Surgical Oncology.

[25]  J. Concato,et al.  To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting. , 2010, American journal of clinical pathology.

[26]  A. Renshaw,et al.  Protocol for the examination of specimens from patients with carcinoma of the prostate gland. , 2009, Archives of pathology & laboratory medicine.

[27]  P. Verhagen,et al.  Histopathological characteristics of lymph node metastases predict cancer‐specific survival in node‐positive prostate cancer , 2008, BJU international.

[28]  F. Burkhard,et al.  Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival , 2008, Histopathology.

[29]  E. Klein,et al.  Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. , 2008, Journal of Urology.

[30]  Badrinath R Konety,et al.  Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. , 2003, The Journal of urology.

[31]  F. Wawroschek,et al.  The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. , 2003, European urology.

[32]  V. Reuter,et al.  Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. , 2001, The Journal of urology.

[33]  M. Kattan,et al.  Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer , 2001, The American journal of surgical pathology.

[34]  J. Thüroff,et al.  Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis , 2000, BJU international.

[35]  M. Banerjee,et al.  Lymph node size does not correlate with the presence of prostate cancer metastasis. , 1999, Urology.

[36]  J. Cheville,et al.  Cancer volume of lymph node metastasis predicts progression in prostate cancer. , 1998, The American journal of surgical pathology.

[37]  A. Ramaswamy,et al.  Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. , 1996, The Journal of urology.

[38]  N. Marcussen,et al.  Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases , 2013, Virchows Archiv.

[39]  Sarah J. Johnson,et al.  Standards and datasets for reporting cancers , 2013 .

[40]  B. Delahunt,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes , 2011, Modern Pathology.

[41]  F. Montorsi,et al.  Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. , 2007, Urology.

[42]  P. Barth,et al.  The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. , 1999, Pathology, research and practice.

[43]  Standards and datasets for reporting cancers Dataset for histopathology reports for prostatic carcinoma June 2016 , 2022 .